Qutenza Related Published Studies
Well-designed clinical trials related to Qutenza (Capsaicin)
Topical capsaicin (low concentration) for chronic neuropathic pain in adults. [2012]
Capsaicin instillation for postoperative pain following total knee arthroplasty: a preliminary report of a randomized, double-blind, parallel-group, placebo-controlled, multicentre trial. [2011.12.01]
A randomized, double-blind, parallel trial comparing capsaicin nasal spray with placebo in subjects with a significant component of nonallergic rhinitis. [2011.08]
Self-reported sleep duration associated with distraction analgesia, hyperemia, and secondary hyperalgesia in the heat-capsaicin nociceptive model. [2011.07]
Effects of lidocaine patch on intradermal capsaicin-induced pain: a double-blind, controlled trial. [2011.03]
A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia. [2011.01]
Effects of lidocaine patch on intradermal capsaicin-induced pain: a double-blind,
controlled trial. [2011]
Effectiveness and safety of topical capsaicin cream in the treatment of chronic soft tissue pain. [2010.12]
Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia. [2010.10.11]
Effects of Lidocaine Patch on Intradermal Capsaicin-Induced Pain: A Double-Blind, Controlled Trial. [2010.10.02]
Efficacy of symptomatic control of knee osteoarthritis with 0.0125% of capsaicin versus placebo. [2010.10]
A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia. [2010.10]
Effect of oral intake of capsaicinoid beadlets on catecholamine secretion and blood markers of lipolysis in healthy adults: a randomized, placebo controlled, double-blind, cross-over study. [2010.07.15]
Capsaicin-induced central sensitization evokes segmental increases in trigger point sensitivity in humans. [2010.07]
A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers. [2010.06]
NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension. [2010.04]
Topical capsaicin therapy for uremic pruritus in patients on hemodialysis. [2010.04]
Capsaicin jelly against migraine pain. [2010.03]
Late sensory function after intraoperative capsaicin wound instillation. [2010.02]
Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974). [2010.01]
Efficacy of symptomatic control of knee osteoarthritis with 0.0125% of capsaicin
versus placebo. [2010]
Effect of duration of postherpetic neuralgia on efficacy analyses in a
multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch
evaluated for the treatment of postherpetic neuralgia. [2010]
A multicenter, randomized, double-blind, controlled dose finding study of
NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic
neuralgia. [2010]
Effect of oral intake of capsaicinoid beadlets on catecholamine secretion and
blood markers of lipolysis in healthy adults: a randomized, placebo controlled,
double-blind, cross-over study. [2010]
Topical capsaicin therapy for uremic pruritus in patients on hemodialysis. [2010]
Late sensory function after intraoperative capsaicin wound instillation. [2010]
A comparison of two formulations of intradermal capsaicin as models of neuropathic pain in healthy volunteers. [2009.10]
Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic pain. [2009.08]
The effect of local anaesthetic on age-related capsaicin-induced mechanical hyperalgesia--a randomised, controlled study. [2009.07]
Vascular and psychophysical effects of topical capsaicin application to orofacial tissues. [2009.06]
Effects of capsaicin, green tea and CH-19 sweet pepper on appetite and energy intake in humans in negative and positive energy balance. [2009.06]
The acute effects of a lunch containing capsaicin on energy and substrate utilisation, hormones, and satiety. [2009.06]
Pharmacokinetic and the effect of capsaicin in Capsicum frutescens on decreasing plasma glucose level. [2009.01]
Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin. [2009.01]
Effects of chili on postprandial gastrointestinal symptoms in diarrhoea predominant irritable bowel syndrome: evidence for capsaicin-sensitive visceral nociception hypersensitivity. [2009.01]
COX-2 inhibition attenuates cough reflex sensitivity to inhaled capsaicin in patients with asthma. [2009]
Effect of morphine and pregabalin compared with diphenhydramine hydrochloride and placebo on hyperalgesia and allodynia induced by intradermal capsaicin in healthy male subjects. [2008.12]
NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. [2008.12]
Capsaicin provocation using two different inhalation devices. [2008.12]
A randomized controlled trial comparing treatment regimens for acute pain for topical oleoresin capsaicin (pepper spray) exposure in adult volunteers. [2008.10]
Inhaled ethanol potentiates the cough response to capsaicin in patients with airway sensory hyperreactivity. [2008.10]
The effect of wound instillation of a novel purified capsaicin formulation on postherniotomy pain: a double-blind, randomized, placebo-controlled study. [2008.07]
Effect of chronic oral gabapentin on capsaicin-induced pain and hyperalgesia: a double-blind, placebo-controlled, crossover study. [2008.07]
Interactions between glutamate and capsaicin in inducing muscle pain and sensitization in humans. [2008.07]
Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. [2008.06.10]
Calcitonin gene-related peptide8-37 antagonizes capsaicin-induced vasodilation in the skin: evaluation of a human in vivo pharmacodynamic model. [2008.04]
Hypersensitivity for capsaicin in patients with functional dyspepsia. [2008.02]
Comparison of topical capsaicin and betamethasone in the treatment of chronic skin lesions due to sulfur mustard exposure. [2008]
Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers. [2007.11]
Reproducibility of the capsaicin-induced dermal blood flow response as assessed by laser Doppler perfusion imaging. [2007.11]
Botulinum toxin A does not alter capsaicin-induced pain perception in human skin. [2007.09.15]
Red chili induces rectal hypersensitivity in healthy humans: possible role of 5HT-3 receptors on capsaicin-sensitive visceral nociceptive pathways. [2007.08.15]
Reaction to topical capsaicin in spinal cord injury patients with and without central pain. [2007.05]
The combined effects of capsaicin, green tea extract and chicken essence tablets on human autonomic nervous system activity. [2007.04]
Enhanced energy expenditure and fat oxidation in humans with high BMI scores by the ingestion of novel and non-pungent capsaicin analogues (capsinoids). [2007.02]
The effect of codeine on the Urge-to-Cough response to inhaled capsaicin. [2007]
Well-designed clinical trials possibly related to Qutenza (Capsaicin)
Civamide cream 0.075% in patients with osteoarthritis of the knee: a 12-week
randomized controlled clinical trial with a longterm extension. [2012]
Systematic Review and Meta-Analysis of Efficacy, Safety, and Tolerability Data from Randomized Controlled Trials of Drugs Used to Treat Postherpetic Neuralgia (December). [2011.11.15]
Oral and cutaneous thermosensory profile of selective TRPV1 inhibition by ABT-102 in a randomized healthy volunteer trial. [2011.05]
Pharmacokinetic/pharmacodynamic relationships of transdermal buprenorphine and fentanyl in experimental human pain models. [2011.04]
The effects of hedonically acceptable red pepper doses on thermogenesis and appetite. [2011.03.01]
Substance P-induced skin inflammation is not modulated by a single dose of sitagliptin in human volunteers. [2011.03]
Oral and cutaneous thermosensory profile of selective TRPV1 inhibition by ABT-102
in a randomized healthy volunteer trial. [2011]
Substance P-induced skin inflammation is not modulated by a single dose of
sitagliptin in human volunteers. [2011]
A pharmacokinetic and pharmacodynamic study of oral oxycodone in a human experimental pain model of hyperalgesia. [2010.12.01]
Long-term low-dose erythromycin in patients with unexplained chronic cough: a double-blind placebo controlled trial. [2010.12]
Transient receptor potential vanilloid type-1 (TRPV-1) channels contribute to cutaneous thermal hyperaemia in humans. [2010.11.01]
Effect of dihydrocapsiate on resting metabolic rate in humans. [2010.11]
Nabilone produces marked impairments to cognitive function and changes in subjective state in healthy volunteers. [2010.11]
Lafutidine prevents low-dose aspirin and loxoprofen induced gastric injury: A randomized, double-blinded, placebo controlled study. [2010.10]
Different therapeutic strategies for burning mouth syndrome: preliminary data. [2010.09]
The effects of training time, sensory loss and pain on human motor learning. [2010.09]
A novel model of inflammatory pain in human skin involving topical application of sodium lauryl sulfate. [2010.09]
Bifidobacterium longum lysate, a new ingredient for reactive skin. [2010.08]
Different effects of morphine and oxycodone in experimentally evoked hyperalgesia: a human translational study. [2010.08]
Effects of intrathecal ketorolac on human experimental pain. [2010.05]
Effect of capsinoids on energy metabolism in human subjects. [2010.01]
Lafutidine prevents low-dose aspirin and loxoprofen induced gastric injury: a
randomized, double-blinded, placebo controlled study. [2010]
Different effects of morphine and oxycodone in experimentally evoked
hyperalgesia: a human translational study. [2010]
The beta-adrenergic antagonist propranolol partly abolishes thermogenic response to bioactive food ingredients. [2009.08]
Evoked human oesophageal hyperalgesia: a potential tool for analgesic evaluation? [2009.08]
Acute effects of a thermogenic nutritional supplement on cycling time to exhaustion and muscular strength in college-aged men. [2009.07.13]
Inhibition of cough-reflex sensitivity by benzonatate and guaifenesin in acute viral cough. [2009.06]
Efficacy of itraconazole in the treatment of patients with chronic cough whose sputa yield basidiomycetous fungi-fungus-associated chronic cough (FACC). [2009.05]
The urge-to-cough and cough motor response modulation by the central effects of nicotine. [2009.04]
Speech pathology for chronic cough: a new approach. [2009.04]
Intranasal Capsicum spray in idiopathic rhinitis: a randomized prospective application regimen trial. [2009.04]
The use of sensory nerve stimulation and compression bandaging to improve sensory nerve function and healing of chronic venous leg ulcers. [2009.03]
Palliative effect of lafutidine on oral burning sensation. [2009.03]
Effects of novel capsinoid treatment on fatness and energy metabolism in humans: possible pharmacogenetic implications. [2009.01]
Immunohistochemical clues at aging of the skin microvascular unit. [2009.01]
Effect of tiotropium on cough reflex sensitivity in acute viral cough. [2008.11]
Effect of topical application of raspberry ketone on dermal production of insulin-like growth factor-I in mice and on hair growth and skin elasticity in humans. [2008.08]
Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers. [2008.07]
Acidification of the oesophagus acutely increases the cough sensitivity in patients with gastro-oesophageal reflux and chronic cough. [2008.02]
Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia. [2008.01]
The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans. [2007.11]
Comparative evaluation of myolaxin and EMLA cream for attenuation of venous cannulation pain: a prospective, randomised, double blind study. [2007.10]
The effect of sensory nerve stimulation on sensory nerve function in people with peripheral neuropathy associated with diabetes. [2007.10]
Management of neuropathic pain. [2007.08]
Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. [2007.02.13]
|
